Literature DB >> 4192939

Immunofluorescence of epithelial skin tumors. I. Patterns of intercellular substance.

J M De Moragas, R K Winkelmann, R E Jordan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4192939     DOI: 10.1002/1097-0142(197006)25:6<1399::aid-cncr2820250620>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  Pemphigus-like antigens and antibodies in benign and malignant neoplasms.

Authors:  R J Ablin; C Aseron
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

2.  Detection of pemphigus-like antigens on tumor cell lines.

Authors:  A R Ahmed; R Murahata
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

3.  Induced pemphigus.

Authors:  V Ruocco; M Pisani
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

4.  Pemphigus antibodies fixation and keratinocyte differentiation in organ cultures. Effects of some agents influencing the intracellular content of cyclic AMP.

Authors:  E Sbano; L Andreassi; M Fimiani; R Baiocchi; M Biagioli
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

5.  Concanavalin-A binding sites, pemphigus antigens, and beta 2 microglobulin in epidermal hyperproliferation, premalignant and malignant lesions.

Authors:  G Mahrle; H Patyk; R Bolling
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

6.  Partial purification and characterization of pemphigus-like antigens in urine.

Authors:  R I Murahata; A R Ahmed
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

7.  Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.

Authors:  A L Krunic; D R Garrod; S Madani; M D Buchanan; R E Clark
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.